{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:58:24Z","timestamp":1790470704628,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU 01.802"],"award-info":[{"award-number":["TTU 01.802"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11262-017-1486-3","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T07:32:53Z","timestamp":1500017573000},"page":"733-740","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Vaccine platform recombinant measles virus"],"prefix":"10.1007","volume":"53","author":[{"given":"Michael D.","family":"M\u00fchlebach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"issue":"1410","key":"1486_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1098\/rstb.2001.0838","volume":"356","author":"RA Weiss","year":"2001","unstructured":"R.A. Weiss, The Leeuwenhoek Lecture 2001, Animal origins of human infectious disease. Philos. Trans. R. Soc. Lond. B. 356(1410), 957\u2013977 (2001). doi:10.1098\/rstb.2001.0838","journal-title":"Philos. Trans. R. Soc. Lond. B."},{"key":"1486_CR2","first-page":"151","volume":"330","author":"D Naniche","year":"2009","unstructured":"D. Naniche, Human immunology of measles virus infection. Curr. Top. Microbiol. Immunol. 330, 151\u2013171 (2009)","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"51","key":"1486_CR3","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.1016\/j.vaccine.2014.10.061","volume":"32","author":"DN Durrheim","year":"2014","unstructured":"D.N. Durrheim, N.S. Crowcroft, P.M. Strebel, Measles - The epidemiology of elimination. Vaccine 32(51), 6880\u20136883 (2014). doi:10.1016\/j.vaccine.2014.10.061","journal-title":"Vaccine"},{"key":"1486_CR4","doi-asserted-by":"publisher","first-page":"16049","DOI":"10.1038\/nrdp.2016.49","volume":"2","author":"PA Rota","year":"2016","unstructured":"P.A. Rota, W.J. Moss, M. Takeda et al., Measles. Nat. Rev. Dis. Primers. 2, 16049 (2016). doi:10.1038\/nrdp.2016.49","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"3","key":"1486_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/qjmed\/hcu113","volume":"108","author":"DL Fisher","year":"2015","unstructured":"D.L. Fisher, S. Defres, T. Solomon, Measles-induced encephalitis. QJM 108(3), 177\u2013182 (2015). doi:10.1093\/qjmed\/hcu113","journal-title":"QJM"},{"issue":"2","key":"1486_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3181\/00379727-86-21073","volume":"86","author":"JF Enders","year":"1954","unstructured":"J.F. Enders, T.C. Peebles, Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc. Soc. Exp. Biol. Med. 86(2), 277\u2013286 (1954)","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"1486_CR7","doi-asserted-by":"crossref","unstructured":"Flint SJ, Racaniello VR, Rall GF (2015) Principles of virology, 4th edition","DOI":"10.1128\/9781555819521"},{"issue":"3","key":"1486_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1001\/archpedi.1962.02080020347030","volume":"103","author":"JF Enders","year":"1962","unstructured":"J.F. Enders, Development of attenuated measles virus vaccines. Am. J. Dis. Child. 103(3), 335 (1962). doi:10.1001\/archpedi.1962.02080020347030","journal-title":"Am. J. Dis. Child."},{"key":"1486_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1056\/NEJM196007282630408","volume":"263","author":"SL Katz","year":"1960","unstructured":"S.L. Katz, C.H. Kempe, F.L. Black et al., Studies on an attenuated measles-virus vaccine. VIII. General summary and evaluation of the results of vaccine. N. Engl. J. Med. 263, 180\u2013184 (1960). doi:10.1056\/NEJM196007282630408","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"1486_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0168-1702(94)90025-6","volume":"31","author":"JS Rota","year":"1994","unstructured":"J.S. Rota, Z.D. Wang, P.A. Rota et al., Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res. 31(3), 317\u2013330 (1994)","journal-title":"Virus Res."},{"issue":"3","key":"1486_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1001\/archpedi.1962.02080020398042","volume":"103","author":"AJF Schwarz","year":"1962","unstructured":"A.J.F. Schwarz, Preliminary tests of a highly attenuated measles vaccine. Arch. Pediatr. Adolesc. Med. 103(3), 386 (1962). doi:10.1001\/archpedi.1962.02080020398042","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"1486_CR12","unstructured":"H.Q. McLean, A.P. Fiebelkorn, J.L. Temte et al., Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2013) 62(RR-04): 1\u201334"},{"issue":"24","key":"1486_CR13","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1016\/j.vaccine.2009.02.066","volume":"27","author":"S Ueda","year":"2009","unstructured":"S. Ueda, Development of measles vaccines in Japan. Vaccine 27(24), 3230\u20133231 (2009). doi:10.1016\/j.vaccine.2009.02.066","journal-title":"Vaccine"},{"issue":"6","key":"1486_CR14","first-page":"571","volume":"49","author":"PN Burgasov","year":"1973","unstructured":"P.N. Burgasov, O.G. Andzaparidze, V.F. Popov, The status of measles after five years of mass vaccination in the USSR. Bull. World Health Organ. 49(6), 571\u2013576 (1973)","journal-title":"Bull. World Health Organ."},{"issue":"2","key":"1486_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0092-8674(80)90515-2","volume":"19","author":"JK Rose","year":"1980","unstructured":"J.K. Rose, Complete intergenic and flanking gene sequences from the genome of vesicular stomatitis virus. Cell 19(2), 415\u2013421 (1980). doi:10.1016\/0092-8674(80)90515-2","journal-title":"Cell"},{"issue":"6","key":"1486_CR16","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/jvi.64.6.2948-2957.1990","volume":"64","author":"AK Pattnaik","year":"1990","unstructured":"A.K. Pattnaik, G.W. Wertz, Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs. J. Virol. 64(6), 2948\u20132957 (1990)","journal-title":"J. Virol."},{"issue":"8","key":"1486_CR17","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1128\/jvi.67.8.4822-4830.1993","volume":"67","author":"P Calain","year":"1993","unstructured":"P. Calain, L. Roux, The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J. Virol. 67(8), 4822\u20134830 (1993)","journal-title":"J. Virol."},{"key":"1486_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0065-3527(08)60373-5","volume":"54","author":"J Curran","year":"1999","unstructured":"J. Curran, D. Kolakofsky, Replication of paramyxoviruses. Adv. Virus Res. 54, 403\u2013422 (1999)","journal-title":"Adv. Virus Res."},{"issue":"18","key":"1486_CR19","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","volume":"13","author":"MJ Schnell","year":"1994","unstructured":"M.J. Schnell, T. Mebatsion, K.K. Conzelmann, Infectious rabies viruses from cloned cDNA. EMBO J. 13(18), 4195\u20134203 (1994)","journal-title":"EMBO J."},{"issue":"23","key":"1486_CR20","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1002\/j.1460-2075.1995.tb00266.x","volume":"14","author":"F Radecke","year":"1995","unstructured":"F. Radecke, P. Spielhofer, H. Schneider et al., Rescue of measles viruses from cloned DNA. EMBO J. 14(23), 5773\u20135784 (1995)","journal-title":"EMBO J."},{"issue":"1","key":"1486_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0166-0934(96)02137-4","volume":"64","author":"H Schneider","year":"1997","unstructured":"H. Schneider, P. Spielhofer, K. Kaelin et al., Rescue of measles virus using a replication-deficient vaccinia-T7 vector. J. Virol. Methods 64(1), 57\u201364 (1997)","journal-title":"J. Virol. Methods"},{"issue":"12","key":"1486_CR22","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1128\/JVI.02389-05","volume":"80","author":"A Martin","year":"2006","unstructured":"A. Martin, P. Staeheli, U. Schneider, RNA polymerase II-controlled expression of antigenomic RNA enhances the rescue efficacies of two different members of the Mononegavirales independently of the site of viral genome replication. J. Virol. 80(12), 5708\u20135715 (2006). doi:10.1128\/JVI.02389-05","journal-title":"J. Virol."},{"issue":"Pt 1","key":"1486_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1099\/0022-1317-80-1-101","volume":"80","author":"M Singh","year":"1999","unstructured":"M. Singh, M.A. Billeter, A recombinant measles virus expressing biologically active human interleukin-12. J. Gen. Virol. 80(Pt 1), 101\u2013106 (1999). doi:10.1099\/0022-1317-80-1-101","journal-title":"J. Gen. Virol."},{"issue":"6","key":"1486_CR24","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1128\/JVI.73.6.4823-4828.1999","volume":"73","author":"M Singh","year":"1999","unstructured":"M. Singh, R. Cattaneo, M.A. Billeter, A recombinant measles virus expressing hepatitis B virus surface antigen induces humoral immune responses in genetically modified mice. J. Virol. 73(6), 4823\u20134828 (1999)","journal-title":"J. Virol."},{"issue":"3","key":"1486_CR25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/j.1460-2075.1987.tb04808.x","volume":"6","author":"R Cattaneo","year":"1987","unstructured":"R. Cattaneo, G. Rebmann, A. Schmid et al., Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J. 6(3), 681\u2013688 (1987)","journal-title":"EMBO J."},{"issue":"11","key":"1486_CR26","doi-asserted-by":"crossref","first-page":"9568","DOI":"10.1128\/JVI.73.11.9568-9575.1999","volume":"73","author":"WP Duprex","year":"1999","unstructured":"W.P. Duprex, S. McQuaid, L. Hangartner et al., Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J. Virol. 73(11), 9568\u20139575 (1999)","journal-title":"J. Virol."},{"issue":"4","key":"1486_CR27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/sj.gt.3302880","volume":"14","author":"HT Ong","year":"2007","unstructured":"H.T. Ong, K. Hasegawa, A.B. Dietz et al., Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies. Gene Ther. 14(4), 324\u2013333 (2007). doi:10.1038\/sj.gt.3302880","journal-title":"Gene Ther."},{"issue":"16","key":"1486_CR28","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1016\/j.vaccine.2007.01.064","volume":"25","author":"A Zuniga","year":"2007","unstructured":"A. Zuniga, Z. Wang, M. Liniger et al., Attenuated measles virus as a vaccine vector. Vaccine 25(16), 2974\u20132983 (2007). doi:10.1016\/j.vaccine.2007.01.064","journal-title":"Vaccine"},{"key":"1486_CR29","first-page":"129","volume":"329","author":"MA Billeter","year":"2009","unstructured":"M.A. Billeter, H.Y. Naim, S.A. Udem, Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses. Curr. Top. Microbiol. Immunol. 329, 129\u2013162 (2009)","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"10","key":"1486_CR30","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1093\/emboj\/21.10.2364","volume":"21","author":"M Rager","year":"2002","unstructured":"M. Rager, S. Vongpunsawad, W.P. Duprex et al., Polyploid measles virus with hexameric genome length. EMBO J. 21(10), 2364\u20132372 (2002). doi:10.1093\/emboj\/21.10.2364","journal-title":"EMBO J."},{"issue":"9","key":"1486_CR31","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1128\/JVI.72.9.7420-7427.1998","volume":"72","author":"B Mrkic","year":"1998","unstructured":"B. Mrkic, J. Pavlovic, T. Rulicke et al., Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72(9), 7420\u20137427 (1998)","journal-title":"J. Virol."},{"issue":"21","key":"1486_CR32","doi-asserted-by":"publisher","first-page":"11546","DOI":"10.1128\/JVI.77.21.11546-11554.2003","volume":"77","author":"C Combredet","year":"2003","unstructured":"C. Combredet, V. Labrousse, L. Mollet et al., A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice. J. Virol. 77(21), 11546\u201311554 (2003)","journal-title":"J. Virol."},{"issue":"1","key":"1486_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.virol.2006.09.049","volume":"360","author":"P Devaux","year":"2007","unstructured":"P. Devaux, V. von Messling, W. Songsungthong et al., Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology 360(1), 72\u201383 (2007). doi:10.1016\/j.virol.2006.09.049","journal-title":"Virology"},{"key":"1486_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1874357901206010012","volume":"6","author":"H Mok","year":"2012","unstructured":"H. Mok, X. Cheng, Q. Xu et al., Evaluation of measles vaccine virus as a vector to deliver respiratory syncytial virus fusion protein or Epstein-Barr virus glycoprotein gp350. Open Virol. J. 6, 12\u201322 (2012). doi:10.2174\/1874357901206010012","journal-title":"Open Virol. J."},{"issue":"3","key":"1486_CR35","doi-asserted-by":"publisher","first-page":"607","DOI":"10.4161\/hv.23242","volume":"9","author":"A Zuniga","year":"2013","unstructured":"A. Zuniga, M. Liniger, T.N.A. Morin et al., Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector. Hum. Vaccin. Immunother. 9(3), 607\u2013613 (2013)","journal-title":"Hum. Vaccin. Immunother."},{"issue":"7","key":"1486_CR36","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.vaccine.2010.12.028","volume":"29","author":"A Sawada","year":"2011","unstructured":"A. Sawada, K. Komase, T. Nakayama, AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats. Vaccine 29(7), 1481\u20131490 (2011). doi:10.1016\/j.vaccine.2010.12.028","journal-title":"Vaccine"},{"issue":"8","key":"1486_CR37","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.vaccine.2010.12.020","volume":"29","author":"ID Iankov","year":"2011","unstructured":"I.D. Iankov, I.H. Haralambieva, E. Galanis, Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein. Vaccine 29(8), 1710\u20131720 (2011). doi:10.1016\/j.vaccine.2010.12.020","journal-title":"Vaccine"},{"issue":"36","key":"1486_CR38","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1016\/j.vaccine.2013.05.086","volume":"31","author":"S Brandler","year":"2013","unstructured":"S. Brandler, C. Ruffie, C. Combredet et al., A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus. Vaccine 31(36), 3718\u20133725 (2013). doi:10.1016\/j.vaccine.2013.05.086","journal-title":"Vaccine"},{"issue":"5","key":"1486_CR39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","volume":"15","author":"K Ramsauer","year":"2015","unstructured":"K. Ramsauer, M. Schwameis, C. Firbas et al., Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Lancet Infect. Dis. 15(5), 519\u2013527 (2015). doi:10.1016\/S1473-3099(15)70043-5","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"1486_CR40","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1371\/journal.pntd.0000096","volume":"1","author":"S Brandler","year":"2007","unstructured":"S. Brandler, M. Lucas-Hourani, A. Moris et al., Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus. PLoS Negl. Trop. Dis. 1(3), e96 (2007). doi:10.1371\/journal.pntd.0000096","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"41","key":"1486_CR41","doi-asserted-by":"publisher","first-page":"6730","DOI":"10.1016\/j.vaccine.2010.07.073","volume":"28","author":"S Brandler","year":"2010","unstructured":"S. Brandler, C. Ruffie, V. Najburg et al., Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses. Vaccine 28(41), 6730\u20136739 (2010). doi:10.1016\/j.vaccine.2010.07.073","journal-title":"Vaccine"},{"issue":"7","key":"1486_CR42","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1080\/21645515.2016.1143576","volume":"12","author":"H-M Hu","year":"2016","unstructured":"H.-M. Hu, H.-W. Chen, Y.-J. Hsiao et al., The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection. Hum Vaccin Immunother 12(7), 1678\u20131689 (2016). doi:10.1080\/21645515.2016.1143576","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"1486_CR43","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/vaccines3030503","volume":"3","author":"IS Harahap-Carrillo","year":"2015","unstructured":"I.S. Harahap-Carrillo, I. Ceballos-Olvera, J.R.-D. Valle, Immunogenic subviral particles displaying domain III of Dengue 2 envelope protein vectored by measles virus. Vaccines 3(3), 503\u2013518 (2015). doi:10.3390\/vaccines3030503. (Basel)","journal-title":"Vaccines"},{"key":"1486_CR44","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.000523","author":"C Swett-Tapia","year":"2016","unstructured":"C. Swett-Tapia, L. Bogaert, P. de Jong et al., Recombinant measles virus incorporating heterologous viral membrane proteins for use as vaccines. J. Gen. Virol. (2016). doi:10.1099\/jgv.0.000523","journal-title":"J. Gen. Virol."},{"issue":"17","key":"1486_CR45","doi-asserted-by":"publisher","first-page":"9013","DOI":"10.1128\/JVI.00906-09","volume":"83","author":"J Reyes-del Valle","year":"2009","unstructured":"J. Reyes-del Valle, G. Hodge, M.B. McChesney et al., Protective anti-hepatitis B virus responses in rhesus monkeys primed with a vectored measles virus and boosted with a single dose of hepatitis B surface antigen. J. Virol. 83(17), 9013\u20139017 (2009). doi:10.1128\/JVI.00906-09","journal-title":"J. Virol."},{"issue":"19","key":"1486_CR46","doi-asserted-by":"publisher","first-page":"10597","DOI":"10.1128\/JVI.00923-07","volume":"81","author":"JR del Valle","year":"2007","unstructured":"J.R. del Valle, P. Devaux, G. Hodge et al., A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge. J. Virol. 81(19), 10597\u201310605 (2007). doi:10.1128\/JVI.00923-07","journal-title":"J. Virol."},{"issue":"21","key":"1486_CR47","doi-asserted-by":"publisher","first-page":"11558","DOI":"10.1128\/JVI.01776-12","volume":"86","author":"J Reyes-del Valle","year":"2012","unstructured":"J. Reyes-del Valle, C. La Fuente, M.A. de Turner et al., Broadly neutralizing immune responses against hepatitis C virus induced by vectored measles viruses and a recombinant envelope protein booster. J. Virol. 86(21), 11558\u201311566 (2012). doi:10.1128\/JVI.01776-12","journal-title":"J. Virol."},{"issue":"6","key":"1486_CR48","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/j.cimid.2010.02.006","volume":"33","author":"M Satoh","year":"2010","unstructured":"M. Satoh, M. Saito, K. Tanaka et al., Evaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD\/Scid\/Jak3null mouse. Comp. Immunol. Microbiol. Infect. Dis. 33(6), e81\u2013e88 (2010). doi:10.1016\/j.cimid.2010.02.006","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"1","key":"1486_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.virol.2009.02.047","volume":"388","author":"M Guerbois","year":"2009","unstructured":"M. Guerbois, A. Moris, C. Combredet et al., Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic. Virology 388(1), 191\u2013203 (2009). doi:10.1016\/j.virol.2009.02.047","journal-title":"Virology"},{"issue":"25\u201326","key":"1486_CR50","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1016\/j.vaccine.2009.01.057","volume":"27","author":"M Liniger","year":"2009","unstructured":"M. Liniger, A. Zuniga, T.N.A. Morin et al., Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses. Vaccine 27(25\u201326), 3299\u20133305 (2009). doi:10.1016\/j.vaccine.2009.01.057","journal-title":"Vaccine"},{"issue":"1","key":"1486_CR51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1128\/JVI.78.1.146-157.2004","volume":"78","author":"C Lorin","year":"2004","unstructured":"C. Lorin, L. Mollet, F. Delebecque et al., A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV. J. Virol. 78(1), 146\u2013157 (2004)","journal-title":"J. Virol."},{"issue":"12","key":"1486_CR52","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00210-012-0793-4","volume":"385","author":"C Lorin","year":"2012","unstructured":"C. Lorin, L. Segal, J. Mols et al., Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques. Naunyn Schmiedebergs Arch Pharmacol 385(12), 1211\u20131225 (2012). doi:10.1007\/s00210-012-0793-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"36","key":"1486_CR53","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1016\/j.vaccine.2005.04.024","volume":"23","author":"C Lorin","year":"2005","unstructured":"C. Lorin, F. Delebecque, V. Labrousse et al., A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes. Vaccine 23(36), 4463\u20134472 (2005). doi:10.1016\/j.vaccine.2005.04.024","journal-title":"Vaccine"},{"issue":"11","key":"1486_CR54","doi-asserted-by":"publisher","first-page":"e50397","DOI":"10.1371\/journal.pone.0050397","volume":"7","author":"R Stebbings","year":"2012","unstructured":"R. Stebbings, M. Fevrier, B. Li et al., Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine. PLoS ONE 7(11), e50397 (2012). doi:10.1371\/journal.pone.0050397","journal-title":"PLoS ONE"},{"issue":"51","key":"1486_CR55","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.1016\/j.vaccine.2013.09.072","volume":"31","author":"R Stebbings","year":"2013","unstructured":"R. Stebbings, B. Li, C. Lorin et al., Immunogenicity of a recombinant measles HIV-1 subtype C vaccine. Vaccine 31(51), 6079\u20136086 (2013). doi:10.1016\/j.vaccine.2013.09.072","journal-title":"Vaccine"},{"key":"1486_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.07.051","author":"G Gupta","year":"2016","unstructured":"G. Gupta, V. Giannino, N. Rishi et al., Immunogenicity of next-generation HPV vaccines in non-human primates: measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine. Vaccine (2016). doi:10.1016\/j.vaccine.2016.07.051","journal-title":"Vaccine"},{"issue":"25\u201326","key":"1486_CR57","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1016\/j.vaccine.2009.01.061","volume":"27","author":"G Cantarella","year":"2009","unstructured":"G. Cantarella, M. Liniger, A. Zuniga et al., Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma. Vaccine 27(25\u201326), 3385\u20133390 (2009). doi:10.1016\/j.vaccine.2009.01.061","journal-title":"Vaccine"},{"issue":"3","key":"1486_CR58","doi-asserted-by":"publisher","first-page":"e0150213","DOI":"10.1371\/journal.pone.0150213","volume":"11","author":"A Higuchi","year":"2016","unstructured":"A. Higuchi, H. Toriniwa, T. Komiya et al., Recombinant measles AIK-C vaccine strain expressing the prM-E antigen of Japanese encephalitis virus. PLoS ONE 11(3), e0150213 (2016). doi:10.1371\/journal.pone.0150213","journal-title":"PLoS ONE"},{"issue":"22","key":"1486_CR59","doi-asserted-by":"publisher","first-page":"11654","DOI":"10.1128\/JVI.01815-15","volume":"89","author":"AH Malczyk","year":"2015","unstructured":"A.H. Malczyk, A. Kupke, S. Prufer et al., A highly immunogenic and protective middle east respiratory syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform. J. Virol. 89(22), 11654\u201311667 (2015). doi:10.1128\/JVI.01815-15","journal-title":"J. Virol."},{"issue":"17\u201319","key":"1486_CR60","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/S0264-410X(00)00523-5","volume":"19","author":"Z Wang","year":"2001","unstructured":"Z. Wang, L. Hangartner, T.I. Cornu et al., Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses. Vaccine 19(17\u201319), 2329\u20132336 (2001)","journal-title":"Vaccine"},{"issue":"1","key":"1486_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2222\/jsv.64.105","volume":"64","author":"M Yoneda","year":"2014","unstructured":"M. Yoneda, Study of pathogenicity of Nipah virus and its vaccine development. Uirusu 64(1), 105\u2013112 (2014). doi:10.2222\/jsv.64.105","journal-title":"Uirusu"},{"issue":"35","key":"1486_CR62","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1016\/j.vaccine.2014.06.024","volume":"32","author":"Y Yamaji","year":"2014","unstructured":"Y. Yamaji, T. Nakayama, Recombinant measles viruses expressing respiratory syncytial virus proteins induced virus-specific CTL responses in cotton rats. Vaccine 32(35), 4529\u20134536 (2014). doi:10.1016\/j.vaccine.2014.06.024","journal-title":"Vaccine"},{"key":"1486_CR63","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.virol.2014.01.002","volume":"452\u2013453","author":"N Escriou","year":"2014","unstructured":"N. Escriou, B. Callendret, V. Lorin et al., Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein. Virology 452\u2013453, 32\u201341 (2014). doi:10.1016\/j.virol.2014.01.002","journal-title":"Virology"},{"issue":"17","key":"1486_CR64","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/j.vaccine.2008.01.057","volume":"26","author":"M Liniger","year":"2008","unstructured":"M. Liniger, A. Zuniga, A. Tamin et al., Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses. Vaccine 26(17), 2164\u20132174 (2008). doi:10.1016\/j.vaccine.2008.01.057","journal-title":"Vaccine"},{"issue":"41","key":"1486_CR65","doi-asserted-by":"publisher","first-page":"5991","DOI":"10.1016\/j.vaccine.2012.06.029","volume":"30","author":"DL Bolton","year":"2012","unstructured":"D.L. Bolton, S. Santra, C. Swett-Tapia et al., Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates. Vaccine 30(41), 5991\u20135998 (2012). doi:10.1016\/j.vaccine.2012.06.029","journal-title":"Vaccine"},{"issue":"2","key":"1486_CR66","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1086\/426824","volume":"191","author":"P Despres","year":"2005","unstructured":"P. Despres, C. Combredet, M.-P. Frenkiel et al., Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. J. Infect. Dis. 191(2), 207\u2013214 (2005). doi:10.1086\/426824","journal-title":"J. Infect. Dis."},{"issue":"2","key":"1486_CR67","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/infdis\/jis328","volume":"206","author":"S Brandler","year":"2012","unstructured":"S. Brandler, P. Marianneau, P. Loth et al., Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection. J. Infect. Dis. 206(2), 212\u2013219 (2012). doi:10.1093\/infdis\/jis328","journal-title":"J. Infect. Dis."},{"issue":"3","key":"1486_CR68","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1128\/JVI.74.3.1364-1372.2000","volume":"74","author":"B Mrkic","year":"2000","unstructured":"B. Mrkic, B. Odermatt, M.A. Klein et al., Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J. Virol. 74(3), 1364\u20131372 (2000)","journal-title":"J. Virol."},{"key":"1486_CR69","unstructured":"ClinicalTrials.gov, An Open-label, Phase I, Dose-escalation and Safety Study of Two Intramuscular Injections of a Dose of 2.9 Log or 4 Log CCID50 of the Recombinant HIV I Clade B Measles Vaccine Vector in Healthy Adults.: NCT01320176. https:\/\/clinicaltrials.gov\/, 2012. Accessed 15 Nov 2016"},{"issue":"9653","key":"1486_CR70","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","volume":"372","author":"SP Buchbinder","year":"2008","unstructured":"S.P. Buchbinder, D.V. Mehrotra, A. Duerr et al., Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372(9653), 1881\u20131893 (2008). doi:10.1016\/S0140-6736(08)61591-3","journal-title":"Lancet"},{"issue":"Pt 5","key":"1486_CR71","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","volume":"72","author":"H Meyer","year":"1991","unstructured":"H. Meyer, G. Sutter, A. Mayr, Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 72(Pt 5), 1031\u20131038 (1991). doi:10.1099\/0022-1317-72-5-1031","journal-title":"J. Gen. Virol."}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11262-017-1486-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-017-1486-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-017-1486-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:58:24Z","timestamp":1744174704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11262-017-1486-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1486"],"URL":"https:\/\/doi.org\/10.1007\/s11262-017-1486-3","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"value":"0920-8569","type":"print"},{"value":"1572-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,14]]},"assertion":[{"value":"17 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no potential conflict of interest. The author is supported by the German Center for Infection Research (DZIF; TTU 01.802).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}